SCR1693 is a selective, reversible, orally active and noncompetitive inhibitor of AChE (IC50 = 0.68 µM) as well as a calcium channel blocker. SCR1693 reduces tau phosphorylation levels, and inhibits the generation and release of Abeta. SCR1693 restores insulin signaling and improves cognitive deficits. SCR1693 can be used for the study of Alzheimers disease, especially which complicated with type 2 diabetes mellitus[1][2][3].
Molecular Weight:
425.95
CAS Number:
[1442559-20-7]
Formula:
C24H28ClN3O2
Target:
Akt,Amyloid-beta,Calcium Channel,Cholinesterase (ChE),GSK-3,Phosphatase,PKA,Tau Protein
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
